Updated indications for the recombinant, adjuvanted RSV vaccine

Description

In this Product Explainer Cardiologist Prof Andrew Sindone provides an update on a recombinant, adjuvanted respiratory syncytial virus (RSV) vaccine.

This educational video was developed by Healthed in collaboration with and with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.
PM-AU-RSA-WCNT-250023. Date of approval: May 2025.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Dennis Lau

Prof Dennis Lau

Postural Orthostatic Tachycardia Syndrome – What You Need to Know

Prof Tony Attwood

Prof Tony Attwood

Autism Assessment in the GP Setting

Prof Brendon Yee, A/Prof Ralph Audehm

Prof Brendon Yee, A/Prof Ralph Audehm

Obstructive Sleep Apnoea – Practical Updates

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Asthma Cases

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Andrew Sindone AM

expert

Prof Andrew Sindone AM

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital

Date published: 27 May 2025